An underground market for unapproved slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.
Investigational Drug Acquiring Traction Online
Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are urged to contact these accounts directly for supplier links, while also obtaining promotional offers.
Thriving Trade on Social Networks
Separately, a robust market exists on Telegram, where communities with numerous of participants share comparison photos, injection guides and assertions of rapid UK delivery. Sellers market the substance there before directing buyers to WhatsApp for transactions.
Learning About Retatrutide
Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.
Healthcare Professionals Voice Concerns
Nevertheless, doctors and chemists have warned that the sale of what is still an unapproved medication in the UK is worrisome and could lead to individuals administering products of uncertain source.
Several experts stated the demand for retatrutide could be linked to the increasing price of licensed weight loss products such as Mounjaro.
Regulatory Position and Implementation
Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved drug that cannot be promoted or supplied for personal consumption under the British medical regulations.
Some content creators try to sidestep the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still breach pharmaceutical, advertising, and customer regulations, potentially leading to penalties, legal action or imprisonment.
Platform Response and Content Removal
According to the social media company, the service has removed problematic content and prohibited associated hashtags and query recommendations. The company said it was dedicated to keeping the platform secure and allocating resources in strengthening enforcement strategies.
Digital Marketplace Operations
Research also discovered communities with up to 9,000 participants marketing retatrutide using the platform's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” instantly displays groups with numerous of members, populated with images of weight loss, positive reviews and step-by-step guides for preparing or administering at residence.
Within moments of entering one group, a seller shared contact information, where the majority of transactions take place. The vendor sent an guidebook and promised shipping within two days. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None asked about body mass, health issues or past usage.
Product Details and Pricing
Within these groups, posts show black plastic packages with Royal Mail stickers, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at residence with sterile water, or pre-filled pens usually priced at £160 for 20 milligrams. When questioned how long a injector should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.
Platform Moderation and Safety Actions
A spokesperson for the messaging service stated it actively moderated harmful content on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are administering materials they cannot confirm. Although the science behind retatrutide is sound, these digital products may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in demand to current cost increases for authorized slimming medications such as Mounjaro. “With costs rising, patients are turning to social media. But fake treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were made in was clean,” she explained.
Her team has previously seen individuals injured by self-injection from unverified sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be contaminated or improperly measured.”
Manufacturer Statement
A representative from the pharmaceutical company stated the substance was in third stage research studies and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this point no one can market [it] for human use,” they explained, noting that any item “falsely representing itself as a company experimental substance not yet approved … may subject users to potentially significant medical dangers”.
